Welcome to DU! The truly grassroots left-of-center political community where regular people, not algorithms, drive the discussions and set the standards. Join the community: Create a free account Support DU (and get rid of ads!): Become a Star Member Latest Breaking News Editorials & Other Articles General Discussion The DU Lounge All Forums Issue Forums Culture Forums Alliance Forums Region Forums Support Forums Help & Search

Jesus Malverde

(10,274 posts)
Thu Aug 22, 2013, 01:12 PM Aug 2013

Merchants of Meth: How Big Pharma Keeps the Cooks in Business

With big profits on the line, the drug industry is pulling out campaign-style dirty tricks to keep selling the meds that cooks turn into crank.

Shake and bake did two things. It took a toxic and volatile process that had once been the province of people with Breaking Bad-style knowledge of chemistry and put it in the bedrooms and kitchens of meth users in rural America. It also produced the most potent methamphetamine anywhere.

If anyone wondered what would happen if heroin or cocaine addicts suddenly discovered how to make their own supply with a handful of cheap ingredients readily available over the counter, methamphetamine's recent history provides an answer. Since 2007, the number of clandestine meth sites discovered by police has increased 63 percent nationwide. In Kentucky, the number of labs has more than tripled. The Bluegrass State regularly joins its neighbors Missouri, Tennessee, and Indiana as the top four states for annual meth lab discoveries.

As law enforcement agencies scramble to clean up and dispose of toxic labs, prosecute cooks, and find foster homes for their children, they are waging two battles: one against destitute, strung-out addicts, the other against some of the world's wealthiest and most politically connected drug manufacturers. In the past several years, lawmakers in 25 states have sought to make pseudoephedrine—the one irreplaceable ingredient in a shake-and-bake lab—a prescription drug. In all but two—Oregon and Mississippi—they have failed as the industry, which sells an estimated $605 million worth of pseudoephedrine-based drugs a year, has deployed all-star lobbying teams and campaign-trail tactics such as robocalls and advertising blitzes.

http://www.motherjones.com/politics/2013/08/meth-pseudoephedrine-big-pharma-lobby

Latest Discussions»Issue Forums»Drug Policy»Merchants of Meth: How Bi...